Clinical Trial Update: A Study of the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting tolerability, safety, and pharmacokinetics of ISU302 in healthy volunteers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• ISU302

Snippet

Sponsor: ISU Abxis Co., Ltd. | Conditions: Gaucher Disease | Phase 1 | Status: COMPLETED